Five things to check before a lifting treatment
This article is not about which clinic is good. It records only what you as a patient can verify for yourself, wherever you go. All five items have evidence you can check — a statute, a court judgement or a public lookup system — and the items that are commonly discussed alongside them but for which we could not find evidence are set out separately at the end.
The conclusion, first
The five are these. ① The device’s approval number — an advertising review number is not an approval number. The two rest on different provisions of law. ② Who performs the treatment — in 2023 a court convicted both the doctor and the nursing assistant in a case where a nursing assistant had been made to carry out radiofrequency lifting. ③ Whether you can watch the consumable being opened — though the legal basis for this is not the provision usually cited. ④ The contract and the refund terms — in official statistics, half of the consumer harm in aesthetic medicine was about contracts, not adverse effects. ⑤ Whether you were given an explanation of adverse effects — and the fact that the incidence figures have no denominator. We did not include the item “cheap prices are dangerous”. That is because we could not find evidence for it.
First, about how this article is written
“Checklist” articles written by clinics tend to run in one direction. They list the items to check, they leave the impression that there are places which do not meet them, and at the end they say that this clinic does.
We do not intend to write that way. There are two reasons.
One is the law. Article 56(2) of the Medical Service Act prohibits advertising that compares a clinic with other medical institutions (subparagraph 4) and advertising that disparages other medical institutions (subparagraph 5). A sentence like “there are clinics like this, so be careful” can be read as either of those two, even without naming anyone.
The other is fact. In preparing this article we traced the sources of the claims that are commonly made, one by one, and the gap between what could be verified and what could not was large. If you write down what cannot be verified as though it were fact, everything else you verified is doubted along with it.
So this article contains no sentence saying “some clinics do this”. Instead it contains only “here is how you can check this”. The judgement is properly yours to make.
One — the device’s approval number. It is a different number from the advertising review number
You have probably seen a number printed on the material describing a lifting device. What is not widely known is that there are two kinds of number.
| Type | Basis | What it is about |
|---|---|---|
| Product approval · certification · notification number | Articles 6(2) and 15(2) of the Medical Devices Act | The safety and performance of the device itself |
| Advertising review number | Article 25 of the Medical Devices Act (self-regulatory review of advertising) | Whether the advertising copy breaches the rules |
An advertising review is valid for three years from the date of approval, and if the content changes it must be reviewed again.
To put it plainly: an advertising review number is not proof that the device has been approved. It is the number given to a review of the advertising copy. When the two numbers appear side by side they are hard to tell apart, and when only one appears it is hard to know which it is.
Using an unapproved device is something the law prohibits directly.
Article 26(1) of the Medical Devices Act — “No one may repair, sell, lease, give or use a medical device that has not been approved or certified, or that has not been notified …”
What matters here is that the word “use” is in the provision. It applies not only to those who distribute the device but to those who use it.
How to check
Since 8 January 2024 the Ministry of Food and Drug Safety (MFDS) has run a public medical device information service. It offers searches by business type — manufacture, import, sale — and a search of the medical devices held by each clinic. The address is emedi.mfds.go.kr.
The simplest method is to ask at your consultation: “Could I have the MFDS approval number for this device?” An approval number is not information anyone has reason to conceal.
One thing to add: with medical devices, the approved name and the trade name used in the market are often different. A different name coming up in a search is not in itself a problem.
Two — who performs the treatment
This item is the clearest, because there is both a statute and a set of judgements.
Article 27(1) of the Medical Service Act — no one who is not a medical practitioner may perform a medical act, and a medical practitioner may not perform a medical act outside the scope of their licence.
On whether aesthetic procedures fall within this, there is a Supreme Court ruling. Supreme Court, 28 June 2007, 2005Do8317 held that cosmetic surgery is also a medical act. On a nursing assistant inserting hair follicles with an implanter down to the dermis, the court held that even with relevant knowledge, so long as the person had not received a doctor’s systematic medical education and a doctor was not substantively involved, the act fell outside the scope of assisting in medical treatment.
There is also a judgement on lifting devices.
| Item | Detail |
|---|---|
| Case | Suwon District Court, Pyeongtaek Branch, 6 February 2023, 2022Godan527 |
| Facts | The director of a medical institution had a nursing assistant carry out radiofrequency lifting, including adjusting the output to prevent burns |
| Sentence | Director a fine of 3 million won / nursing assistant a fine of 1 million won (suspended for one year) |
| Finding as to the nursing assistant | Given the device specification, the layout of the facility and the cost of the treatment, she knew or could have known that it was a medical act |
For balance, however, there is another judgement we should mention. Jeju District Court, 2 May 2019, 2018No334 acquitted a doctor who had instructed a nursing assistant to remove molluscum contagiosum, holding that if the act was assistance in medical treatment carried out under the doctor’s proper direction and supervision, its unlawfulness could be negated.
In other words the issue is not only “whose hands did it” but “did it go beyond the scope of assisting in treatment, and was the doctor substantively involved”. Leaving that distinction out and writing “it is always illegal if a nursing assistant does it” would not be accurate either.
How to check
At your consultation, simply ask “who will be performing today’s treatment?” And on the day, look at whether the person who actually comes in is the person you were told about. Those two things are all there is to it.
Three — the consumable. Though the legal basis is not the provision usually cited
The cartridge of an ultrasound lifting device has a set number of shots it can deliver. On the question of reusing this consumable, an explanation is widely circulated online that it is “a breach of the ban on reusing single-use medical devices under the Medical Service Act”.
As far as we have verified, that explanation is not accurate.
It is true that Article 4(6) of the Medical Service Act prohibits the reuse of single-use medical devices. But which devices those are is set by the Enforcement Rule and by Ministry of Health and Welfare Public Notice No. 2022-404 (23 May 2022), and the list is this — catheters inserted into sterile tissue, intravascular catheters, drainage catheters and containers, implantable medical devices, devices related to Creutzfeldt-Jakob disease, and devices suspected of being an epidemiological factor in an outbreak of infection.
Ultrasound lifting cartridges are not on that list. So the phrase “a breach of the ban on single-use reuse under the Medical Service Act” is legally incorrect.
That does not mean there is no rule at all. The provision that actually applies is elsewhere.
Article 26(4) of the Medical Devices Act — “No one, in using a medical device, may … alter or modify it so as to differ from the content that was approved, certified or notified”
If the cartridge’s approved specification sets out a number of uses and single use, then resetting that count or refilling its contents amounts to alteration or modification differing from the approved content — that is the legally accurate account.
What we could not verify — and this part matters
We looked for the following three things, and we could not verify any of them.
- A press release or safety letter in which the MFDS addressed the reuse of lifting cartridges specifically
- Academic literature reporting infection or burns caused by cartridge reuse — there is literature on the reprocessing of single-use medical devices in general, but not on this consumable
- Official statistics giving the scale of non-genuine consumable distribution in Korea
So we cannot write “reuse causes infection”. We could not find the evidence. We open cartridges in the consulting room for a reason unrelated to this dispute — so that the patient can see it for themselves.
How to check
One sentence is enough: “could I watch the cartridge being opened?” Opening it immediately before the treatment is the norm, so there is no reason in the sequence of events for this to be difficult.
Four — the contract and refund terms. In official statistics, the most common problem
This item sits in an unexpected place. Among consumer harm related to aesthetic medicine, the most frequent category was not adverse effects but contracts.
| Category | Cases | Share |
|---|---|---|
| Contract-related | 163 | 50.6% |
| Adverse effects | 124 | 38.5% |
| Insufficient effect | 23 | 7.2% |
| Total | 322 | — |
The 163 contract-related cases broke down into 97 refusals of refund and 66 refunds of the balance after excessive deductions. In the same survey, 92 instances of improper advertising were found at 71 of 190 institutions (37.4%).
Please read the year along with the figures. This was published in 2021 and covers two years of applications received in 2019–2020. Within the range we checked, we could not find any aesthetic · cosmetic redress statistics updated since then. It is not data that should be called “recent statistics”.
Lifting is often carried out over several sessions or bundled across several areas, which makes prepayment easy to fall into. That is why this item is in practice the one that most often causes trouble.
How to check
- What happens to the remaining sessions if you stop partway — whether a refund is possible, and on what basis deductions are made
- Whether that basis is in writing — terms you were only told verbally cannot be checked later
- Whether you can change the area or the treatment — how the remaining sessions can be used if your condition changes
Here is where we explain why the item “cheap prices are dangerous” is not in this article. We could not find, anywhere in Korea or abroad, a study demonstrating a relationship between the price of aesthetic treatments and the rate of adverse effects. It is a claim without evidence, so we did not write it. What does have evidence is not whether the price is high or low but whether the refund terms are clear.
Five — whether you were told about adverse effects, and the limits of those numbers
The safety of the lifting family of treatments is reported as broadly good in a number of studies. Let us say that first, before anything else.
| Study | Size | Figures reported |
|---|---|---|
| Safety study in Asian subjects (2011) | 49 Chinese subjects · 68 treatments, mean age 53.3 | Local bruising up to 25%, 2 cases of post-inflammatory hyperpigmentation, pain during treatment rated ‘severe’ by 54.4%. No permanent or delayed adverse effects up to 6 months |
| Systematic review + meta-analysis (2020) | 17 studies · 477 subjects | Mean pain 4.2/10, no pigmentation reported. “Safe in the short term”, long-term data lacking |
| Korean retrospective study (2023) | 36 subjects (20 alone · 16 combined with radiofrequency) | Mild erythema · oedema 70% / 44%, all resolving within 2 days. No nerve dysfunction |
| Systematic review (2025) | 45 papers | Oedema 10–20%, tenderness 15–25%, nerve stimulation under 1%, unintended fat atrophy under 1% |
There is, however, a reason these numbers should not be read at face value.
We could not find a paper giving the incidence of burns. The material reporting blistering · erosion · ulceration · atrophy · skin necrosis was a case series of five patients, and the vision-related complication was a case report of one 50-year-old woman. A case report has no denominator. That means you cannot know how many out of how many.
A 2025 literature review (22 papers examined) wrote about this problem directly — that the included studies “did not report exact patient percentages”.
So we do not tell patients flatly that “the rate of adverse effects is such-and-such a percentage”. The numbers in the table above are what each study observed under its own conditions; they are not established incidence figures for this treatment.
There is one item worth watching carefully. In the review of 45 papers fat atrophy was rare, under 1%, but its cause was written down as “inappropriate choice of depth”. In other words this is less a matter of probability than a matter of planning.
How to check
See whether adverse effects come up first in the consultation. And you can ask this — “might this not suit me?” If the answer that comes back is “that will not happen”, it is an answer that matches none of the studies in the table above.
What we left off the checklist — because we could not find evidence
| Item | Why it is not included |
|---|---|
| Cheap prices are dangerous | We could not find, anywhere in Korea or abroad, a study demonstrating a relationship between the price of aesthetic treatments and the rate of adverse effects |
| Reusing consumables causes infection | We could not find academic literature dealing with the reuse of this consumable |
| Large numbers of non-genuine devices are in circulation | We could not verify official statistics giving the scale of distribution in Korea. There is material issued by manufacturers, but with no figures and no regulatory action it is hard to use as evidence |
| Promotional prices cut costs on the consumables | There is no evidence, and as a statement pointing at a particular group of clinics it is also inappropriate under the Medical Service Act |
These four do not mean “this is not true”; they mean “we could not verify it”. We try not to write down what we could not verify as though it were fact.
On the condition ‘in Daegu’
The five items in this article have nothing to do with region. The statutes, the case law and the lookup systems are the same across the country.
There is, though, a point at which region does enter into actually choosing a clinic. Distance. Lifting does not usually end in one visit, there are cases where a check afterwards is needed, and if a reaction is not what was expected you have to be able to come back.
So the advice we give is not “choose somewhere close” but “if it is a distance you would find hard to travel again, decide with that in mind”. Aftercare is part of the same episode of treatment.
Miso Clinic is on the 4th floor of the Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, 322 m from Exit 1 of Kyungpook National University Hospital station. Recording the location is information, not the conclusion of this article.
Summary — what we verified and what we could not
| Category | Detail |
|---|---|
| Verified | Approval numbers and advertising review numbers rest on different provisions and the review is valid for three years / Article 26(1) of the Medical Devices Act prohibits even the ‘use’ of an unapproved device / cosmetic surgery is also a medical act (Supreme Court 2005Do8317) / in the case where a nursing assistant carried out radiofrequency lifting, both the director and the nursing assistant were convicted (2022Godan527) / the ban on altering or modifying a consumable is Article 26(4) of the Medical Devices Act / 50.6% of aesthetic medical harm was a contract problem (published 2021) |
| Inferred | The reading that manipulating a cartridge’s use count amounts to ‘alteration or modification’ — it follows from the wording of the provision, but we could not verify an authoritative interpretation stating it |
| Could not verify | Any relationship between price and adverse effects / literature on infection or burn risk from consumable reuse / the scale of non-genuine distribution / the incidence of burns / redress statistics later than 2021 |
| Evidence pointing the other way | Treatment by a nursing assistant is not always unlawful; if it is within the scope of assisting in treatment under a doctor’s substantive direction and supervision, its unlawfulness may be negated (Jeju District Court 2018No334) / the overall safety of the lifting family is reported as good in a number of studies, and accounts that exaggerate adverse effects run against the literature |
Reduced further, the five items are five questions.
- Could I have the approval number for this device?
- Who will be performing today’s treatment?
- Could I watch the cartridge being opened?
- If I stop partway, what happens to the remaining sessions?
- Might this not suit me?
None of the five are hard questions to answer. That is why we think they are worth asking.
Frequently asked questions
If there is an advertising review number, does that mean the device is approved?
No. The two numbers rest on different provisions of law. A product approval, certification or notification number is issued under Articles 6(2) and 15(2) of the Medical Devices Act and concerns the safety and performance of the device itself, whereas an advertising review number is issued under Article 25 (self-regulatory review of advertising) for a review of the advertising copy. An advertising review is valid for three years from the date of approval and must be reviewed again if the content changes. So an advertising review number is not proof that the device has been approved.
Where do I check a medical device approval number?
Since 8 January 2024 the Ministry of Food and Drug Safety (MFDS) has run a public medical device information service (emedi.mfds.go.kr). It offers searches by business type — manufacture, import, sale — and a search of the medical devices held by each clinic. The simplest method, though, is to ask directly at your consultation. An approval number is not information anyone has reason to conceal. One thing to keep in mind is that with medical devices the approved name and the trade name used in the market are often different, so a search may return a different name.
Is it illegal for a nursing assistant to carry out a lifting treatment?
It is hard to state flatly, and there are judgements on both sides. In 2023 the Pyeongtaek Branch of the Suwon District Court fined a clinic director 3 million won and a nursing assistant 1 million won (suspended for one year) in a case where the director had the nursing assistant use a radiofrequency lifting device. Supreme Court 2005Do8317 held that cosmetic surgery is also a medical act, and that where a nursing assistant went beyond the scope of assisting in medical treatment the act could not be regarded as justifiable. On the other hand, Jeju District Court 2018No334 acquitted, holding that where the act was assistance in treatment carried out under a doctor’s proper direction and supervision, its unlawfulness could be negated. The issue is whether the scope of assisting in treatment was exceeded and whether the doctor was substantively involved.
Is reusing a cartridge a breach of the Medical Service Act?
The provision usually cited is not the accurate one. It is true that Article 4(6) of the Medical Service Act prohibits the reuse of single-use medical devices, but ultrasound lifting cartridges are not on the list of devices covered (Ministry of Health and Welfare Public Notice No. 2022-404). The provision that actually applies is Article 26(4) of the Medical Devices Act, which prohibits altering or modifying a device so as to differ from what was approved, certified or notified. If the cartridge’s approved specification sets out a number of uses and single use, then resetting that count falls within it — that is the legally accurate account. However, we could not find academic literature reporting infection or burns caused by reuse.
Are cheaper places dangerous?
We could not find evidence supporting this claim. We could not verify, anywhere in Korea or abroad, a study demonstrating a correlation between the price of aesthetic treatments and the rate of adverse effects. What does have evidence lies elsewhere. In material published by the Korea Consumer Agency in 2021 (322 applications received in 2019–2020), 50.6% of the harm was contract-related and 38.5% was adverse effects. Of the 163 contract-related cases, 97 were refusals of refund. In other words, whether prepayment and refund terms are clear in writing is the item actually worth checking, rather than whether the price is high or low.
What percentage of lifting treatments have adverse effects?
This cannot be stated flatly. A 2025 systematic review of 45 papers summarised nerve stimulation as under 1% and unintended fat atrophy as under 1%, and a 2020 meta-analysis of 17 studies with 477 subjects found mean pain of 4.2/10 with no pigmentation reported. But we could not find a paper giving the incidence of burns. The material reporting blistering, ulceration and necrosis was a case series of five patients, and it has no denominator. A 2025 review of 22 papers wrote directly that the included studies did not report exact patient percentages.
What happens if fat atrophy occurs?
In the systematic review of 45 papers it was reported as rare, at under 1%. What matters, though, is that the same review described its cause as "inappropriate choice of depth". In other words it is less an accident that happens at random than a matter of planning — of deciding at what depth and how much to deliver. That is why the process of checking skin thickness and fat volume before treatment carries more meaning on the safety side than on the efficacy side. We have set out this part separately in another article.
When choosing a clinic in Daegu, is the region itself a criterion?
The statutes, the case law and the lookup systems are the same across the country, so the five items in this article have nothing to do with region. Distance, though, does enter into it. Lifting does not usually end in one visit, there are cases where a check afterwards is needed, and if a reaction is not what was expected you have to be able to come back. So this does not mean choose somewhere close; it means that if it is a distance you would find hard to travel again, decide with that in mind. Aftercare is part of the same episode of treatment.
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- The distinction between an approval number and an advertising review number was confirmed from the text of Articles 6(2) and 15(2) of the Medical Devices Act (product approval · certification · notification) and Article 25 (self-regulatory review of advertising, review valid for three years from the date of approval). The ban on the “use” of an unapproved medical device is Article 26(1) of the Medical Devices Act, and the ban on alteration · modification is paragraph 4 of the same Article. The provisions were checked on the Korean Law Information Center.
- The public lookup service is the medical device information service (emedi.mfds.go.kr) launched by the MFDS on 8 January 2024. Automated access to the exact menu paths inside the site was restricted, so we could not verify them directly.
- The list of devices covered by the ban on reusing single-use medical devices is Ministry of Health and Welfare Public Notice No. 2022-404 (23 May 2022), ‘List of single-use medical devices whose reuse is prohibited’, and ultrasound lifting cartridges are not included.
- The case law on who performs treatment is Supreme Court, 28 June 2007, 2005Do8317 (cosmetic surgery is also a medical act; departure from the scope of assisting in medical treatment), Suwon District Court, Pyeongtaek Branch, 6 February 2023, 2022Godan527 (radiofrequency lifting — director fined 3 million won · nursing assistant fined 1 million won suspended for one year) and Jeju District Court, 2 May 2019, 2018No334 (acquittal, treated as assistance in medical treatment under a doctor’s direction and supervision). The governing provision is Article 27 of the Medical Service Act.
- The consumer harm statistics are the Korea Consumer Agency, ‘Consumer harm relating to aesthetic · cosmetic medical services is common’, published 25 May 2021 (period covered 2019–2020, 322 redress applications, contract-related 163 · 50.6% — 97 refusals of refund · 66 refunds of the balance, adverse effects 124 · 38.5%, insufficient effect 23 · 7.2%, improper advertising found at 71 of 190 institutions · 37.4% in 92 instances). Automated access to the press release page itself was restricted, so we verified this through news coverage quoting the original PDF, and we could not find statistics updated after 2022.
- The adverse event figures are Chan NP et al., Lasers Surg Med 2011 (49 Chinese subjects · 68 treatments, mean age 53.3 — local bruising up to 25%, 2 cases of post-inflammatory hyperpigmentation, pain rated ‘severe’ by 54.4%, no permanent or delayed adverse effects up to 6 months), Ayatollahi A et al., Lasers Med Sci 2020 (17 studies · 477 subjects — mean pain 4.2/10, no pigmentation reported), Lee SK et al., Medical Lasers 2023 (Korean retrospective, 36 subjects — mild erythema · oedema 70% / 44%, all resolving within 2 days) and Haykal D et al., Aesthet Surg J 2025;45(7):690 (45 papers — oedema 10–20%, tenderness 15–25%, nerve stimulation under 1%, fat atrophy under 1% — cause given as “inappropriate choice of depth”). In Haykal 2025 the erythema figures differ between the table and the text, so we did not cite erythema.
- The severe complications are Friedmann DP et al., Lasers Surg Med 2018;50 (retrospective multicentre case series of 5 — no denominator: blistering · erosion · ulceration · atrophy · skin necrosis) and Rechuan MM et al., An Bras Dermatol 2023 (case report of 1 — acute angle-closure glaucoma, partial remission at 6 months). The limitation on calculating incidence is Biskanaki F et al., Applied Sciences 2025 (22 papers examined), which stated directly that the studies “did not report exact patient percentages”.
- What we recorded as “could not find” — a study demonstrating a relationship between the price of aesthetic treatments and the rate of adverse effects; academic literature on the infection · burn risk of reusing lifting cartridges; material in which the MFDS addressed the reuse of this consumable specifically; official statistics on the scale of non-genuine consumable distribution in Korea; the incidence of burns (%); aesthetic · cosmetic redress statistics updated after 2021.
- This article does not evaluate or compare any particular medical institution, and does not guarantee the effect of any particular treatment. Indications and expected outcomes differ according to individual condition, and a consultation is required.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia